Patent Licensing Negotiation

FRAND (Fair, Reasonable, and Non-Discriminatory) licensing commitments apply to standard-essential patents (SEPs) — patents that are technically necessary to comply with a technology standard (e.g., 4G/5G cellular, Wi-Fi, Bluetooth, HEVC video). Standards bodies (ETSI, IEEE, ITU, etc.) require members who declare patents as essential to commit to licensing on FRAND terms. FRAND prevents SEP holders from demanding supra-competitive royalties that exploit the standard lock-in. Courts in the U.S., Europe, and Asia have developed varying approaches to determining what rate is FRAND — typically looking at comparable licenses, the patent pool rate, and the value of the patent to the standard.

Royalty stacking occurs when a single product implements many different patented technologies, each with its own royalty obligation. A smartphone, for example, may incorporate hundreds of SEPs from dozens of patent holders, each demanding a royalty on the device's total sales price. If all holders demanded their individual maximum FRAND rate, the total could exceed the product's selling price — an economically irrational result. Courts use the royalty stacking concern as a reason to favor royalty bases tied to the component rather than the entire device. The royalty stacking problem is central to debates about whether FRAND royalties should be calculated on the smallest salable patent-practicing unit (SSPPU) or the end product.

SSPPU is a damages methodology principle that restricts the royalty base to the smallest identifiable component that actually embodies the patented technology. For a patent on a modem chip function in a smartphone, the SSPPU is the modem chip, not the entire phone. In Ericsson v. D-Link (Fed. Cir. 2014), the court held that the SSPPU is a factor to consider but not a strict rule — courts must use the royalty base and rate that together yield a reasonable royalty. In Commonwealth Scientific v. Cisco (Fed. Cir. 2015), the court allowed a royalty calculated on the end product price where the royalty rate appropriately accounted for the patent's contribution to the whole device.

Key leverage factors in patent licensing negotiations include: (1) Patent quality — are the patents strong (clear infringement, valid over prior art) or weak (narrow, subject to IPR challenge)? (2) Claim breadth — do claims cover the competitor's actual products without design-arounds? (3) Litigation threat credibility — can the licensor afford and win a lawsuit? (4) Standard-essentiality — SEP holders have inherent leverage from lock-in but are constrained by FRAND. (5) Cross-licensing value — does the licensee have a patent portfolio that the licensor needs? (6) Market position — is the licensee a major customer whose product drives adoption? (7) Walk-away value — what happens if no deal is reached (injunction, product recall, market exit)?

Patent license structures include: (1) Exclusive license — licensee is the only entity with rights (must include all fields of use or be narrower); patent owner typically retains right to practice. (2) Non-exclusive license — multiple licensees permitted; most common in cross-licensing. (3) Field-of-use restriction — rights granted only for a specific application (medical use only; automotive use only). (4) Royalty structures: running royalty (% of revenue per unit), lump-sum paid-up license, milestone-based (royalty steps at revenue thresholds), or combination. (5) Cross-license — each party grants rights to the other's portfolio; common between large tech companies. (6) Portfolio license — covers all patents in a portfolio rather than specific patents.